S
SANA BIOTECHNOLOGY INC
NASDAQ: SANA (Sana Biotechnology, Inc.)
最近更新时间: 7小时之前3.06
0.05 (1.66%)
市场趋势
短期 | 中期 | ||
行业 | Biotechnology (US) | 混合的 | 看跌 |
Biotechnology (全球的) | 混合的 | 看跌 | |
股票 | Sana Biotechnology, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
-0.1
分析师共识 | 3.0 |
内部交易活动 | NA |
价格波动 | -2.0 |
技术平均移动指标 | 1.0 |
技术振荡指标 | -2.5 |
平均 | -0.13 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others. |
|
部门 | Healthcare |
行业 | Biotechnology |
投资方式 | Small Value |
内部持股比例 | 8.46% |
机构持股比例 | 89.37% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Canada Pension Plan Investment Board | 30 Jun 2025 | 10,175,000 |
Crestline Management, Lp | 30 Jun 2025 | 2,420,937 |
Integral Health Asset Management, Llc | 30 Jun 2025 | 1,500,000 |
52周波幅 | ||
目标价格波幅 | ||
高 | 12.00 (Morgan Stanley, 292.16%) | 购买 |
中 | 8.50 (177.78%) | |
低 | 5.00 (JMP Securities, 63.40%) | 购买 |
平均值 | 8.50 (177.78%) | |
总计 | 2 购买 | |
平均价格@调整类型 | 3.08 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Morgan Stanley | 03 Jul 2025 | 12.00 (292.16%) | 购买 | 3.19 |
JMP Securities | 24 Jun 2025 | 5.00 (63.40%) | 购买 | 2.97 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合